MedTrace Logo

HERrespect Evaluation

NCT03304015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1195

Last updated 2019-12-20

No results posted yet for this study

Summary

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of violence in the workplace. This is a quasi-experimental study involving four intervention and four control factories.

Conditions

  • IPV
  • Workplace Violence

Interventions

BEHAVIORAL

Behavioral Change Communications

HERrespect is developed by Business for Social Responsibility (BSR) and Change Associates. HERproject is one of BSR's numerous initiatives for improving women's lives through enhancement of access and knowledge (BSR, 2015). The factory-based component of HERrespect will be implemented by Change Associates. The intervention group will receive training (group session), research and consultancy services to the corporate and development sectors. HERrespect proposes to use the workplace as an incubator of dialogue among men and women to tackle underlying issues which allow violence against women and girls. Workplace offers a unique platform and environment to engage women who are gaining financial independence to reduce intimate partner violence and workplace violence.

Sponsors & Collaborators

  • Medical Research Council, South Africa

    collaborator OTHER

  • BSR

    collaborator UNKNOWN

  • Change Associates Limited

    collaborator UNKNOWN

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-03
Primary Completion
2019-10-31
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03304015 on ClinicalTrials.gov